ACTIVE

APOTHEEK VUNCKX-PEETERS

Financial year 2025 · Closed on 31/12/2025

Net result5,9 k €-5,7 %over 1 year
Gross margin5,7 k €+30,4 %over 1 year
Equity174,9 k €+3,5 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK VUNCKX-PEETERS is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Anderlecht.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0897.964.137
Incorporation
08/05/2008
Legal form
Private limited company
Registered office
Square Marie Curie 30
1070 Anderlecht · BruxellesSee on map
Contributed capital
18 550,00 €
Latest accounts
31/12/2025
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 18 filings

Trend over 11 financial years

20252024202320222021
Income statement
Gross margin5,7 k €4,4 k €3,4 k €6,2 k €5,9 k €
EBITDA4,7 k €3,9 k €2,8 k €5,8 k €5,4 k €
Operating result4,1 k €3,2 k €2,2 k €5,1 k €4,8 k €
Net result5,9 k €6,3 k €4,9 k €4,4 k €3,7 k €
Balance sheet
Equity174,9 k €169 k €162,7 k €157,8 k €153,4 k €
Total assets175,1 k €173,8 k €164,3 k €158,9 k €157,8 k €
Cash22,5 k €23,6 k €36,1 k €34,3 k €91,5 k €
Debts178 €4,8 k €1,6 k €1,1 k €4,3 k €
Other
Workforce–––––

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Geert Reyniers

Director · since 28 février 2025

Active

Ended mandates

Popelin Apotheken

Director · since 11 juin 2024 · until 28 février 2025 · 1004.967.609

Represented by Jan Kuyps

Ended
Goed Farma

Director · since 27 septembre 2017 · until 11 juin 2024 · 0400.789.251

Represented by Jan Kuys

Ended
Goed Farma

Director · since 27 septembre 2017 · 0400.789.251

Represented by Jasmien Coenen

Ended
Goed Farma

Manager · since 27 septembre 2017 · 0400.789.251

Represented by Jan Kuyps

Ended

Other companies at this address

Square Marie Curie 30 1070 Anderlecht
CompanyCBE no.
0440.256.175
0454.105.203
0458.570.666
DE ZEVEN HOEKEN● Active
0461.480.369
DLA● Active
0639.768.151
Goed Aalter● Active
0808.051.471
Multipharma● Active
0866.855.346
0401.995.516
0406.518.090
1004.967.609
TALPA FARMA● Active
0686.929.353

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date25/06/202612/08/202527/06/202405/07/202306/07/202219/07/2021
General meeting11/06/202623/06/202511/06/202413/06/202314/06/202215/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202511/06/202625/06/2026DutchPDF
Abridged model31/12/202423/06/202512/08/2025DutchPDF
Abridged model31/12/202311/06/202427/06/2024DutchPDF
Abridged model31/12/202213/06/202305/07/2023DutchPDF
Abridged model31/12/202114/06/202206/07/2022DutchPDF
Abridged model31/12/202015/06/202119/07/2021DutchPDF
Abridged model31/12/201930/06/202017/07/2020DutchPDF
Full model31/12/201823/05/201914/06/2019DutchPDF
Abridged model31/12/201724/05/201820/06/2018DutchPDF
Abridged model31/12/201612/06/201731/07/2017DutchPDF
Abridged model31/12/201513/06/201630/08/2016DutchPDF
Abridged model31/12/201408/06/201528/08/2015DutchPDF
Abridged model31/12/201309/06/201425/08/2014DutchPDF
Abridged modelCorrection31/12/201210/06/201309/10/2013DutchPDF
Abridged model31/12/201210/06/201301/08/2013DutchPDF
Abridged model31/12/201111/06/201223/07/2012DutchPDF
Abridged model31/12/201013/06/201104/08/2011DutchPDF
Abridged model31/12/200914/06/201008/07/2010DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 6 ended

Active mandates

Geert Reyniers

Director · since 28 février 2025

Active

Ended mandates

Popelin Apotheken

Director · since 11 juin 2024 · until 28 février 2025 · 1004.967.609

Represented by Jan Kuyps

Ended
Goed Farma

Director · since 27 septembre 2017 · until 11 juin 2024 · 0400.789.251

Represented by Jan Kuys

Ended
Goed Farma

Director · since 27 septembre 2017 · 0400.789.251

Represented by Jasmien Coenen

Ended
Goed Farma

Manager · since 27 septembre 2017 · 0400.789.251

Represented by Jan Kuyps

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other03/10/2025
    WIJZIGING VAN DE VERTEGENWOORDIGER VAN DE COMMISSARIS
    PDF
  • Mandates11/03/2025
    ONTSLAG EN BENOEMING VAN BESTUURDERS - VOLMACHTEN TOT
    PDF
  • Registered office06/03/2025
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates16/09/2024
    Ontslagen en benoemingen
    PDF
  • Registered office18/07/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other15/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Mandates09/11/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates19/11/2021
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20255,9 k €↓
  2. 2024
    Annual accounts 20246,3 k €↑
  3. 2023
    Annual accounts 20234,9 k €↑
  4. 2022
    Annual accounts 20224,4 k €↑
  5. 2021
    Annual accounts 20213,7 k €↓
  6. 2020
    Annual accounts 20203,7 k €↓
  7. 2019
    Annual accounts 20194,4 k €↓
  8. 2012
    Annual accounts 201220,3 k €↓
  9. 2011
    Annual accounts 201127,1 k €↑
  10. 2010
    Annual accounts 201024,7 k €↓
  11. 2009
    Annual accounts 200960 k €
  12. 08/05/2008
    IncorporationPrivate limited company